Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C

Tarik Asselah ¹, Ivan Bièche , Ingrid Laurendeau

⁰Service d'Hépatologie and INSERM CRB3, AP-HP Hôpital Beaujon, University of Paris VII, Paris, France. tarikasselah@hotmail.com

Gastroenterology +

|

December 14, 2005

View abstract on PubMed

Summary

Hepatitis C virus (HCV) infection alters liver gene expression, particularly during fibrosis progression. Key genes in extracellular matrix turnover and immune response distinguish mild from moderate fibrosis, aiding in diagnosis.

Area Of Science

Hepatology
Molecular Biology
Virology

Background

Limited understanding of liver gene expression changes during chronic Hepatitis C Virus (HCV) infection.
Specific focus on the transition from mild to moderate liver fibrosis.

Purpose Of The Study

To investigate changes in liver gene expression during HCV infection progression.
To identify key genes associated with the transition from mild (F1) to moderate (F2) fibrosis.

Main Methods

Utilized real-time quantitative RT-PCR to analyze mRNA expression of 240 selected genes.
Compared gene expression in pooled liver specimens (F1 vs. F2) and individual samples (F1-F4).
Identified genes with at least a 2-fold expression difference between fibrosis stages.

Main Results

Identified 22 up-regulated genes in F2 samples compared to F1, primarily involved in cytoskeleton, growth factors, extracellular matrix, and cell junctions.
Hierarchical clustering using 11 key genes accurately classified F1 and F2 samples (83% and 90% accuracy, respectively).
Gene expression changes from normal liver to F1 (interferon-inducible genes) differed significantly from F1 to F2 changes.

Conclusions

Genes related to extracellular matrix turnover and immune response are crucial in the progression from mild to moderate fibrosis.
Eleven identified genes can serve as a gene expression signature for differentiating mild from moderate fibrosis in chronic HCV patients.

Related Concept Videos